Free Trial
NYSE:THC

Tenet Healthcare (THC) Stock Price, News & Analysis

Tenet Healthcare logo
$190.37 -3.76 (-1.94%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$191.01 +0.64 (+0.34%)
As of 05/8/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Tenet Healthcare Stock (NYSE:THC)

Advanced

Key Stats

Today's Range
$188.88
$198.43
50-Day Range
$177.02
$244.10
52-Week Range
$146.60
$247.21
Volume
1.24 million shs
Average Volume
1.67 million shs
Market Capitalization
$16.40 billion
P/E Ratio
9.90
Dividend Yield
N/A
Price Target
$244.16
Consensus Rating
Moderate Buy

Company Overview

Tenet Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
84th Percentile Overall Score

THC MarketRank™: 

Tenet Healthcare scored higher than 84% of companies evaluated by MarketBeat, and ranked 98th out of 859 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tenet Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on no strong buy ratings, 19 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside Potential

    Tenet Healthcare has a consensus price target of $244.16, representing about 28.3% upside from its current price of $190.37.

  • Amount of Analyst Coverage

    Tenet Healthcare has been the subject of 16 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Tenet Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Tenet Healthcare are expected to grow by 0.11% in the coming year, from $17.56 to $17.58 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tenet Healthcare is 9.90, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.13.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tenet Healthcare is 9.90, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 20.79.

  • Price to Earnings Growth Ratio

    Tenet Healthcare has a PEG Ratio of 1.29. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Tenet Healthcare has a P/B Ratio of 2.44. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Tenet Healthcare's valuation and earnings.
  • Short Interest

    There is no current short interest data available for THC.
  • Dividend Yield

    Tenet Healthcare does not currently pay a dividend.

  • Dividend Growth

    Tenet Healthcare does not have a long track record of dividend growth.

  • News Sentiment

    Tenet Healthcare has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 19 news articles for Tenet Healthcare this week, compared to 6 articles on an average week.
  • Search Interest

    10 people have searched for THC on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Tenet Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tenet Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $10,943,111.00 in company stock.

  • Percentage Held by Insiders

    0.81% of the stock of Tenet Healthcare is held by insiders.

  • Percentage Held by Institutions

    95.44% of the stock of Tenet Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Tenet Healthcare's insider trading history.
Receive THC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tenet Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

THC Stock News Headlines

$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…tc pixel
See More Headlines

THC Stock Analysis - Frequently Asked Questions

Tenet Healthcare's stock was trading at $198.75 at the start of the year. Since then, THC shares have decreased by 4.2% and is now trading at $190.37.

Tenet Healthcare Corporation (NYSE:THC) announced its earnings results on Thursday, April, 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.21 by $0.61. The company's revenue was up 2.6% on a year-over-year basis.
Read the conference call transcript
.

Tenet Healthcare's board authorized a stock buyback program on Wednesday, July 24th 2024, which permits the company to repurchase $1,500,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 10.3% of its shares through open market purchases. Shares buyback programs are often a sign that the company's management believes its stock is undervalued.

Tenet Healthcare subsidiaries include these companies: SurgCenter Development, United Surgical Partners International, European Surgical Partners Ltd., Aspen Healthcare, Emanuel Medical Center, Texas Regional Medical in Sunnyvale, Vanguard Health Systems, and more.

Tenet Healthcare's top institutional investors include Dimensional Fund Advisors LP (1.39%), Bank of New York Mellon Corp (0.69%), Allspring Global Investments Holdings LLC (0.34%) and Hsbc Holdings PLC (0.30%). Insiders that own company stock include Saumya Sutaria, James L Bierman, Tammy Romo, Richard J Mark, Paola M Arbour, Nadja West, J Robert Kerrey, Lisa Y Foo, Meghan Fitzgerald, Christopher S Lynch, Richard W Fisher, Thomas W Arnst and R Scott Ramsey.
View institutional ownership trends
.

Shares of THC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tenet Healthcare investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
4/30/2026
Today
5/09/2026
Bank of America Global Healthcare Conference 2026
5/13/2026
Next Earnings (Estimated)
7/28/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - HOSPITALS
Sub-Industry
Health Care Facilities
Current Symbol
NYSE:THC
CIK
70318
Employees
99,000
Year Founded
1969

Price Target and Rating

High Price Target
$288.00
Low Price Target
$210.00
Potential Upside/Downside
+28.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
22 Analysts

Profitability

EPS (Trailing Twelve Months)
$19.23
Trailing P/E Ratio
9.90
Forward P/E Ratio
10.84
P/E Growth
1.27
Net Income
$1.41 billion
Net Margins
7.94%
Pretax Margin
14.76%
Return on Equity
25.55%
Return on Assets
5.15%

Debt

Debt-to-Equity Ratio
1.96
Current Ratio
1.36
Quick Ratio
1.30

Sales & Book Value

Annual Sales
$21.31 billion
Price / Sales
0.77
Cash Flow
$27.71 per share
Price / Cash Flow
6.87
Book Value
$77.93 per share
Price / Book
2.44

Miscellaneous

Outstanding Shares
86,140,000
Free Float
85,439,000
Market Cap
$16.40 billion
Optionable
Optionable
Beta
1.30

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:THC) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners